Edgewise Therapeutics, Inc. (EWTX) Misses Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts EWTX Hot Sheet
Join SI Premium – FREE
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q4 EPS of ($0.47), $0.04 worse than the analyst estimate of ($0.43).
For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras CEO says investors misunderstood margin guidance
- Micron posts record profit as AI memory demand fuels explosive growth
- MillerKnoll, Inc. (MLKN) Tops Q4 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
